The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of neoadjuvant chemotherapy using gemcitabine and S1 before surgery for pancreatic cancer on quality of life.
 
Naoko Sato
No Relationships to Disclose
 
Fuyuhiko Motoi
Consulting or Advisory Role - TEIJIN PHARMA
Speakers' Bureau - Taiho Pharmaceutical
 
Masahiro Iseki
No Relationships to Disclose
 
Kei Kawaguchi
No Relationships to Disclose
 
Fumiko Sato
No Relationships to Disclose
 
Yu Katayose
No Relationships to Disclose
 
Michiaki Unno
Honoraria - Abbvie; Asahi Kasei; Astellas Pharma; Chugai Pharma; Daiichi Sankyo; EA Pharma; Eisai; Johnson & Johnson; Lilly; Mylan; Novartis; Taiho Pharmaceutical; Takeda; Teijin Pharma; Yakult Honsha
Research Funding - Asahi Kasei (Inst); Astellas Pharma (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Toyama Chemical Co (Inst); Yakult Honsha (Inst)